IL1B and neoplasm: MSCs are originally silent but become aggressive after receiving activation signals from tumor-derived pro-inflammatory cytokines, such as TNFα and IL1β, and/or ligation of the TLRs, such as TLR2, TLR3, and TLR4, that are expressed on MSCs [108,109].